DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Cigna - 1 Eli Lilly - 1 Rahul Rao - 1 It’s - 1 Raja Krishnamoorthi - 1 PBMs - 1
Top related locs:
U.S FTC’s Vermont
Top related orgs:
Federal Trade Commission - 1 FTC - 1 CVS - 1 Cigna's - 1 Zinc Health - 1 Ascent Health - 1 Emisar Pharma Services - 1 UnitedHealth - 1

Search resuls for: "Ascent Health"


3 mentions found


☆ Federal Trade Commission accuses three drug middlemen of inflating insulin prices
  + stars: | 2024-09-20 | by ( Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms Mirna-Alsharif-Byline-Jm.Jpg | Mirna Alsharif | ) www.nbcnews.com   time to read: +3 min
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. PBMs work with insurance companies to negotiate discounted prices from drug companies in exchange for including the drugs in their coverage. The drug was priced at $274 in 2017, as a result of the PBMs rebate system strategy, the FTC said. In July, Democratic and Republican lawmakers blamed executives from Caremark, Express Scripts and Optum Rx for sky-high prescription drug prices in the U.S. during an oversight committee hearing. The lawsuit also comes as states — most recently Vermont — have sued PBMs, alleging they drive up drug costs.
Persons: Cigna, Eli Lilly, Rahul Rao, It’s, Raja Krishnamoorthi, PBMs Organizations: Federal Trade Commission, FTC, CVS, Cigna's, Zinc Health, Ascent Health, Emisar Pharma Services, UnitedHealth, CVS Health, Novo Nordisk, Democratic, Republican, Caremark, New York Times, Republicans, ” Rep Locations: U.S, FTC’s, Vermont
☆ US FTC expands probe into pharmacy benefit managers
  + stars: | 2023-05-17 | by ( ) www.reuters.com   time to read: +1 min
May 17 (Reuters) - The U.S. Federal Trade Commission said it had sought information from two privately held companies that negotiate drug rebates on behalf of pharmacy benefit managers (PBMs) as part of its probe into how PBMs affect pricing of prescription drugs. The two companies, Zinc Health Services and Ascent Health Services, are group purchasing organizations, that negotiate after-market discounts or rebates with drug manufacturers on behalf of PBMs and hold the contracts that govern those rebates. Zinc Health negotiates rebates for CVS Health Corp (CVS.N) and Ascent Health for Cigna Group's (CI.N) Express Scripts unit and Prime Therapeutics, which is a privately held PBM, the FTC said on Wednesday. PBMs act as middlemen and negotiate rebates and fees with drug manufacturers, create lists of medications that are covered by insurance, and reimburse pharmacies for patients' prescriptions. Reporting by Manas Mishra in Bengaluru Editing by Vinay DwivediOur Standards: The Thomson Reuters Trust Principles.
☆ The next big thing in Big Tech career path is an AI-based 'bilingual' job skillset
  + stars: | 2023-04-02 | by ( Eric Rosenbaum | ) www.cnbc.com   time to read: +8 min
Microsoft unveiled new versions of its Bing internet-search engine and Edge browser powered by the newest technology from ChatGPT maker OpenAI. But the biggest one of all may be next, he says, through the combination of artificial intelligence and branches of science involved in medicine. But the opportunity won't translate into achievement without a new form of collaboration between the classic big tech talent and the medical field. One of her portfolio companies, Insitro, was founded by Stanford AI researcher Daphne Koller (Koller co-founder edtech company Coursera). "There is lots of exciting big talent opportunities coming from big tech and big cap pharma," she said.
0 next >>
Total: 3